PrEP Uptake, Adherence and Retention for African American MSM in Mississippi

Multiple Principal Investigators
Amy Nunn, ScD
Philip Chan, MD (The Miriam Hospital)
Leandro Mena, MD (University of Mississippi Medical Center) 

Sponsor: National Institutes of Health (NIH)/National Institute of Mental Health

Grant Number:
1 R34MH1 0937 1-01A1

Young, African American men who have sex with men (YMSM) in the Deep South are disproportionately impacted by the HIV/AIDS epidemic. A once daily medication (emtricitabine/tenofovir) known as pre-exposure prophylaxis (PrEP) can dramatically reduce HIV acquisition among MSM but behavioral and social challenges undermine its optimal uptake, use and efficacy. This proposal by early stage investigators develops and tests a pilot intervention designed to enhance PrEP adherence and retention in care for AA YMSM in Mississippi. The findings of this research will be used to help define the essential elements of a prevention intervention to overcome barriers to PrEP adherence and retention in care among AA YMSM, and will be uniquely tailored to the social and health policy contexts relevant for African American men in the Deep South.